FDA Offers Recommendations on Highlights Section of Labeling
By Michael Mezher -
Published 18 January 2018
The US Food and Drug Administration (FDA) on Thursday issued draft guidance providing recommendations on completing certain portions of the Highlights section of labeling for prescription drugs and biologics.
Categories: News, US, FDA, Biologics and biotechnology, Drugs, Labeling
Tags: Highlights, Prescribing Information, Physician Labeling Rule